Adrian Hardy - 18 Jun 2026 Form 4 Insider Report for Inotiv, Inc. (NOTV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Jun 2026, 16:06:58 UTC
Prior SEC filing
18 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Beth Taylor, Attorney-in-Fact for Adrian Hardy

Key filing fact

Adrian Hardy filed Form 4 for Inotiv, Inc. (NOTV) on 23 Jun 2026.

Key facts

  • This page summarizes Adrian Hardy's Form 4 filing for Inotiv, Inc. (NOTV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Jun 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 18 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727631 Primary reporting owner

Hardy Adrian

Relationship
Chief Commercial Officer
Address
2701 KENT AVENUE, WEST LAFAYETTE
Signature
/s/ Beth Taylor, Attorney-in-Fact for Adrian Hardy
Signature date
23 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NOTV transaction

Common Stock

Tax liability

Transaction value
Shares
-5,371
Change %
-9.2%
Price
$0.0185*
Shares after
53,049
Date
18 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by Inotiv, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .